The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20201495: Unilever N.V.; The LIV Group Inc.
20201499: Trident VIII, L.P.; Revere Parent, Inc.
20201501: Cognizant Technology Solutions Corporation; Pamlico Capital III, L.P.
20201502: Carlyle Partners VII, L.P.; Victory Innovations Company, Inc.
20201504: MRI Parent Holdings, LLC; Thomas C. Priore
20201505: Genstar Capital Partners IX, L.P.; Utopia Investment Holdings, LLC
20201506: Cove Hill Partners Fund I, L.P.; Vista Equity Endeavor Fund I, L.P.
20201507: Trine Acquisition Corp.; Desktop Metal, Inc.
20201510: GI Partners Fund V LP; Charlesbank Equity Fund VII, Limited Partnership
2009003 Informal Interpretation
FTC Staff Comment to Texas Health and Human Services Commission Regarding Certificate of Public Advantage Applications
FTC Staff Comment to Attorney General of Texas Concerning Certified Registered Nurse Anesthetists (CRNA) Regulations
Elanco Animal Health and Bayer
In July 2020, the FTC required global suppliers of animal products, Elanco Animal Health, Inc. and Bayer Animal Health GmbH, to divest three animal health products to settle charges that Elanco’s proposed $7.6 billion acquisition of Bayer would likely be anticompetitive in those markets. On Sept. 11, 2020, the Commission announced the final consent agreement in this matter.